Lysine

Lysine

SCHEMBL3821052

CCC(N)(N)C(=O)O.NC(=O)O.NCCCC[C@H](N)C(=O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.62
NOS1 P29475 8/20 0.44
NOS2 P35228 8/20 0.44
NOS3 P29474 5/20 0.44
CYP1A2 P05177 2/20 0.44
TSHR P16473 2/20 0.44
CYP3A4 P08684 1/20 0.44
DDAH1 O94760 3/20 0.43
BLM P54132 1/20 0.43
CYP2C19 P33261 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ARG2 P78540 4/20 0.41
ARG1 P05089 3/20 0.41
GNAI3 P08754 1/20 0.40
GNAO1 P09471 1/20 0.40
GNAI1 P63096 1/20 0.40
GLA P06280 1/20 0.40
NFKB1 P19838 1/20 0.40
APEX1 P27695 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL3821051 1.00 GSR (0.62) GSRNOS1NOS2NOS3CYP1A2
Ornithine Aketoglutarate SCHEMBL53032 0.92 GSR (0.58) GSRNOS1NOS2NOS3CYP1A2
Ornithine SCHEMBL53033 0.92 GSR (0.58) GSRNOS1NOS2NOS3CYP1A2
Lysine SCHEMBL7048440 0.83 GSR (0.71) GSRNOS1NOS2NOS3CYP1A2
Lysine SCHEMBL7048439 0.83 GSR (0.71) GSRNOS1NOS2NOS3CYP1A2
Lysine SCHEMBL5060018 0.83 GSR (0.91) GSRNOS1NOS2NOS3CYP1A2
Lysine SCHEMBL4641859 0.83 GSR (0.91) GSRNOS1NOS2NOS3CYP1A2
Lysine SCHEMBL31644218 0.83 GSR (0.91) GSRNOS1NOS2NOS3CYP1A2
Lysine SCHEMBL31039861 0.83 GSR (0.91) GSRNOS1NOS2NOS3CYP1A2
Lysine SCHEMBL7040784 0.82 GSR (0.74) GSRNOS1NOS2NOS3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2089425-A2 ANTI-ANGIOGENIC COMPOUNDS CovX Technologies Ireland Limited (IE) 2009-08-19 EP disclosed
WO-2008056346-A2 ANTI-ANGIOGENIC COMPOUNDS COVX TECHNOLOGIES IRELAND LIMITED (IE) 2008-05-15 WO disclosed